Role of Positron Emission Tomography (PET/CT) in Primary Mediastinal Large B Cell Lymphoma (PMLBCL): Preliminary Results of an International Phase II Trial (IELSG-26 Study) Conducted On Behalf of the International Extranodal Lymphoma Study Group (IELSG), the Fondazione Italiana Linfomi (FIL) and the UK NCRI Lymphoma Group
Luca Ceriani(St Thomas' Hospital), Maurizio Martelli(University of Milan), Silvia Montoto(Queen Mary University of London), Armando López‐Guillermo(Barcelona Supercomputing Center), Maria Giuseppina Cabras(University of Cagliari), Erica Finolezzi, Monica Balzarotti(IRCCS Humanitas Research Hospital), Elena Porro(Institute of Oncology Research), Caterina Stelitano(University of Reggio Calabria), Paolo Paesano, Franco Cavalli(Institute of Social and Preventive Medicine), Luca Giovanella(University of Zurich), Francesco Merli(Azienda Sanitaria Unità Locale di Reggio Emilia), Andrew Davies(University Hospital Southampton NHS Foundation Trust), Flavia Salvi(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Luigi Rigacci(Azienda Ospedaliero-Universitaria Careggi), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Emanuele Zucca(Università della Svizzera italiana), Chiara Rusconi(Fondazione IRCCS Istituto Nazionale dei Tumori), Graziella Pinotti(Medica (Italy)), Umberto Vitolo(Candiolo Cancer Institute), Ercole Brusamolino(University of Pavia), Peter Johnson(Cancer Research UK)
Cited by 5
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k